These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 35741014)

  • 21. Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice.
    Cao LL; Guan PP; Zhang SQ; Yang Y; Huang XS; Wang P
    J Neuroinflammation; 2021 Dec; 18(1):281. PubMed ID: 34861878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis.
    de Dios C; Abadin X; Roca-Agujetas V; Jimenez-Martinez M; Morales A; Trullas R; Mari M; Colell A
    Transl Neurodegener; 2023 Mar; 12(1):10. PubMed ID: 36895045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Role of Neuronal NLRP1 Inflammasome in Alzheimer's Disease: Bringing Neurons into the Neuroinflammation Game.
    Yap JKY; Pickard BS; Chan EWL; Gan SY
    Mol Neurobiol; 2019 Nov; 56(11):7741-7753. PubMed ID: 31111399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
    J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caspase-6 Is a Key Regulator of Innate Immunity, Inflammasome Activation, and Host Defense.
    Zheng M; Karki R; Vogel P; Kanneganti TD
    Cell; 2020 Apr; 181(3):674-687.e13. PubMed ID: 32298652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ZBP1 and TAK1: Master Regulators of NLRP3 Inflammasome/Pyroptosis, Apoptosis, and Necroptosis (PAN-optosis).
    Malireddi RKS; Kesavardhana S; Kanneganti TD
    Front Cell Infect Microbiol; 2019; 9():406. PubMed ID: 31850239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necroptosis and Alzheimer's Disease: Pathogenic Mechanisms and Therapeutic Opportunities.
    Zhang R; Song Y; Su X
    J Alzheimers Dis; 2023; 94(s1):S367-S386. PubMed ID: 36463451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis).
    Samir P; Malireddi RKS; Kanneganti TD
    Front Cell Infect Microbiol; 2020; 10():238. PubMed ID: 32582562
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining PANoptosis: Biochemical and Mechanistic Evaluation of Innate Immune Cell Death Activation.
    Tweedell RE; Hibler T; Kanneganti TD
    Curr Protoc; 2024 Jul; 4(7):e1112. PubMed ID: 39073015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence.
    Lee S; Karki R; Wang Y; Nguyen LN; Kalathur RC; Kanneganti TD
    Nature; 2021 Sep; 597(7876):415-419. PubMed ID: 34471287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
    Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
    Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain.
    Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A
    J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
    Thawkar BS; Kaur G
    J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From pyroptosis, apoptosis and necroptosis to PANoptosis: A mechanistic compendium of programmed cell death pathways.
    Wang Y; Kanneganti TD
    Comput Struct Biotechnol J; 2021; 19():4641-4657. PubMed ID: 34504660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease.
    Rui W; Xiao H; Fan Y; Ma Z; Xiao M; Li S; Shi J
    J Neuroinflammation; 2021 Dec; 18(1):280. PubMed ID: 34856990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammasome Involvement in Alzheimer's Disease.
    Olsen I; Singhrao SK
    J Alzheimers Dis; 2016 Jun; 54(1):45-53. PubMed ID: 27314526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer's rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway.
    Abdelhady R; Younis NS; Ali O; Shehata S; Sayed RH; Nadeem RI
    Inflammopharmacology; 2023 Oct; 31(5):2719-2729. PubMed ID: 37458952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newly Identified Function of Caspase-6 in ZBP1-mediated Innate Immune Responses, NLRP3 Inflammasome Activation, PANoptosis, and Host Defense.
    Zheng M; Kanneganti TD
    J Cell Immunol; 2020; 2(6):341-347. PubMed ID: 33426542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory aspects of Alzheimer's disease.
    Botella Lucena P; Heneka MT
    Acta Neuropathol; 2024 Aug; 148(1):31. PubMed ID: 39196440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.